Pal -Glu (OSu)-OH Succinimidyl Ester CAS 294855-91-7
Khoom npe: (S)-5-((2,5-dioxopyrrolidin-1-yl)oxy)-5-oxo-2-palmitamidopentanoic acid
Lwm Lub Npe: Pal-Glu(OSu)-OH
MF: C25H42N2O7
PIB: 482.61
CAS: 294855-91-7 Nr
Hauj lwm lawm
cov khoom paub meej
MF:
C25H42N2O7
CAS:
294855-91-7
Xim:
Dawb los yog Off-dawb hmoov
Pob ntawv:
Nquag pob: 25kg / hnab / nruas;
Rau cov qauv: 100gram / lub raj mis; 50gram / hnab;
Product Overview
Pal-Glu(OSu)-OH Succinimidyl Ester (CAS 294855-91-}7) yog ib qho tshuaj bioconjugation reagent nrog cov tshuaj muaj npe N{5}}Palmitoyl-L-glutamic Acid N-Hydroxysuccinimide Ester. Nws cov qauv molecular muaj ob qho tib si palmitoyl hydrophobic saw thiab ib pawg succinimidyl ester (OSu) reactive, featuring lipophilicity thiab reactivity. Nws ua haujlwm raws li qhov tseem ceeb nruab nrab rau kev hloov pauv molecular hauv biomedical thiab cov ntaub ntawv tshawb fawb.
Daim ntawv pov thawj zoo
Ua raws li ISO 9001 qhov system zoo; Txhua pawg yog nrog los ntawm Daim Ntawv Pov Thawj Kev Ntsuam Xyuas (COA) nrog rau kev kuaj purity, infrared spectroscopy (IR) thiab lwm cov ntaub ntawv pov thawj
Product Quality Standard
Peb lub tuam txhab muaj cov kws tshaj lij R & D pab neeg thiab pab pawg tsim khoom. Rau Pal-Glu(OSu)-OH, peb tuaj yeem muab cov phiaj xwm ntau lawm.
1. Purity Ntau dua los yog sib npaug rau 98.00%, tsis muaj qhov yuav tsum tau hais txog Cov Khoom Siv thiab Isomer.
2. Purity Ntau dua los yog sib npaug rau 98.00%, Txhua yam khoom ntawm Cov Khoom Siv Hluav Taws Xob muaj xws li NOLGMATBE & HOSU thiab Max ib qho impurity.
3. Rau Isomer, Yog tias koj xav tau tus qauv, peb yuav sim Isomer rau koj.
4. Cia Cia: Lub tsev khaws khoom ib txwm khaws qhov kub thiab txias, qhuav, zam lub teeb.
Peb cov khoom
Hais txog peb
Peb lub tuam txhab tsuas yog tsim cov tshuaj intermediates, catalysts thiab tshuaj zoo.
Peb lub tuam txhab tam sim no muaj kev tshaj lij thiab ruaj khov siv tshuab thiab lub zog. Peb tsom mus rau cov tshuaj nruab nrab xws li Semaglutide intermediate, Tirzepatide intermediate, Retatrutide intermediate thiab Liraglutide intermediate.
Cov hauv qab no yuav qhia txog lwm yam khoom.
Daim ntawv thov tseem ceeb
Biomolecular Modification:Siv rau kev hloov pauv ntawm palmitoylation ntawm biomolecules xws li cov proteins, peptides, thiab cov tshuaj tiv thaiv kab mob txhawm rau txhim kho cov lipophilicity molecular thiab cell membrane permeability
Drug Delivery Systems:Ua haujlwm nruab nrab rau cov neeg nqa khoom lipid hauv kev npaj cov phiaj xwm nanoparticles thiab liposomes, ua kom cov tshuaj ua kom zoo dua qub - tso tawm cov teebmeem thiab bioavailability
Material Surface Functionalization:Hloov kho qhov chaw ntawm cov ntaub ntawv biocompatible (xws li, kho mob polymers, nanocarriers) los qhia cov qauv amphiphilic thiab txhim kho cov khoom siv biocompatibility
Cosmetic Ingredient Synthesis:Siv nyob rau hauv kev npaj cov khoom xyaw nquag nrog txhim kho cov tawv nqaij nkag mus, pab cov khoom xyaw ua haujlwm kom nkag mus tob rau hauv daim tawv nqaij
Kev tshawb fawb biomedical:Ua raws li qhov nruab nrab rau molecular probes hauv kev tshawb fawb scenarios xws li xov tooj ntawm tes taw qhia txoj hauv kev thiab receptor binding mechanisms
Cim npe nrov: pal-glu(osu)-oh succinimidyl ester cas 294855-91-7, Tuam Tshoj pal-glu(osu)-oh succinimidyl ester cas 294855-91-7 manufacturers, lwm tus neeg, Hoobkas
Xa kev nug
Koj Tseem Yuav Zoo Li
